Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.16467 http://scihub22266oqcxt.onion/10.18632/oncotarget.16467 C5514966!5514966!28415635     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncotarget 2017 ; 8 (23): 37974-90 Nephropedia Template TP {{tp|p=28415635|t=2017. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target |pdf=|usr=}}{{28415635}} gab.com Text Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28415635 #FOAvip Epigenetic modifications in cancer stem cells largely result in phenotypic and functional heterogeneity in many solid tumors. Increasing evidence indicates that enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb repressor complex 2, is highly expressed in cancer stem cells of numerous malignant tumors and has a critical function in cancer stem cell expansion and maintenance. Here, we review up-to-date information regarding EZH2 expression patterns, functions, and molecular mechanisms in cancer stem cells in various malignant tumors and discuss the therapeutic potential of targeting EZH2 in tumors. Twit Text FOAVip Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=28415635 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28415635 #FOAvip English Wikipedia <ref>{{Cite pmid|28415635}}</ref> Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target #MMPMID28415635 Wen Y; Cai J; Hou Y; Huang Z; Wang Z Oncotarget 2017[Jun]; 8 (23): 37974-90 PMID28415635show ga Epigenetic modifications in cancer stem cells largely result in phenotypic and functional heterogeneity in many solid tumors. Increasing evidence indicates that enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb repressor complex 2, is highly expressed in cancer stem cells of numerous malignant tumors and has a critical function in cancer stem cell expansion and maintenance. Here, we review up-to-date information regarding EZH2 expression patterns, functions, and molecular mechanisms in cancer stem cells in various malignant tumors and discuss the therapeutic potential of targeting EZH2 in tumors. äRole of EZH2 in cancer stem cells: from biological insight to a therap(epmc).pdf DeepDyve Pubget Overpricing